Dan Fabris

Explores the next generation of RNA-based drug therapies targeting infectious diseases such as HIV

The World Within Reach
Contact the Office of Media Relations at (518) 956-8150

Dan Fabris

College of Arts and Sciences
Department: Chemistry

Using Mass spectroscopy to investigate macromolecular complexes; protein-nucleic acid interactions in viruses; high-resolution mass spectrometry; RNA-based drug therapeutics

Campus phone: 437-4464
Campus email: dfabris@albany.edu


Professor of Chemistry and Biology Daniele Fabris is the director of the RNA MassSpec Center, part of the RNA Institute. Fabrs leads a team of researchers at UAlbany dedicated to exploring and developing the next generation of RNA-based drug therapies specifically targeting infectious diseases, such as HIV.

Fabris was recently awarded a $1,768,690 grant from the National Institutes of General Medical Sciences (NIGMS) to analyze RNA-based therapeutic strategies in the treatment of HIV.

Equipped with a state-of-the-art collection of instruments and enabling technologies provided through the RNA Institute's strategic partnerships, Fabris and his colleagues are embarking on projects aimed at reaching a greater understanding of the role of noncoding RNA in gene regulation and viral replication. These insights will lead to the identification of possible targets for early drug discovery that could produce alternative drugs for resistant strains of infectious diseases and new treatments for orphan diseases.